GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (HKSE:03320) » Definitions » FCF Yield %

China Resources Pharmaceutical Group (HKSE:03320) FCF Yield % : 35.04 (As of May. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, China Resources Pharmaceutical Group's Trailing 12-Month Free Cash Flow is HK$13,582 Mil, and Market Cap is HK$38,763 Mil. Therefore, China Resources Pharmaceutical Group's FCF Yield % for today is 35.04%.

The historical rank and industry rank for China Resources Pharmaceutical Group's FCF Yield % or its related term are showing as below:

HKSE:03320' s FCF Yield % Range Over the Past 10 Years
Min: 3.57   Med: 19.27   Max: 46.29
Current: 35.04


During the past 11 years, the highest FCF Yield % of China Resources Pharmaceutical Group was 46.29%. The lowest was 3.57%. And the median was 19.27%.

HKSE:03320's FCF Yield % is ranked better than
98.05% of 1079 companies
in the Drug Manufacturers industry
Industry Median: -0.48 vs HKSE:03320: 35.04

China Resources Pharmaceutical Group's FCF Margin % for the quarter that ended in Dec. 2023 was 15.24%.


China Resources Pharmaceutical Group FCF Yield % Historical Data

The historical data trend for China Resources Pharmaceutical Group's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Pharmaceutical Group FCF Yield % Chart

China Resources Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.42 23.86 43.52 22.73 42.14

China Resources Pharmaceutical Group Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.00 -29.14 68.87 -26.95 120.11

Competitive Comparison of China Resources Pharmaceutical Group's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Pharmaceutical Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Pharmaceutical Group's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Pharmaceutical Group's FCF Yield % distribution charts can be found below:

* The bar in red indicates where China Resources Pharmaceutical Group's FCF Yield % falls into.



China Resources Pharmaceutical Group FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

China Resources Pharmaceutical Group's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=13581.639 / 32229.2763
=42.14%

China Resources Pharmaceutical Group's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=19355.483 * 2 / 32229.2763
=120.11%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Resources Pharmaceutical Group FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


China Resources Pharmaceutical Group FCF Yield % Related Terms

Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Pharmaceutical Group (HKSE:03320) Business Description

Traded in Other Exchanges
Address
26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, HKG
CR Pharma, is a vertically integrated conglomerate that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the third largest drug distributor by revenue, with a strong presence in Eastern, Northern, and Southern China. Its drug manufacturing segment primarily consists of four listed subsidiaries, Dong E E Jiao, CR Sanjiu, CR Double Crane, and Jiangzhong Pharmaceutical, which are well-known makers of over-the-counter traditional Chinese medicines (or TCM), health supplements, and prescription drugs. We estimate the company's operating income is approximately 53% distribution, 46% manufacturing, and less than 1% retail pharmacies.

China Resources Pharmaceutical Group (HKSE:03320) Headlines

No Headlines